Vincerx Pharma, Inc. Earnings Per Share (Diluted)
Vincerx Pharma, Inc. reported Earnings Per Share (Diluted) of -$1.40 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-05-15
- Vincerx Pharma, Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$1.40.
- Vincerx Pharma, Inc. earnings per share, diluted for the quarter ending 2024-12-31 was $81.63, a 1.80% decline year-over-year.
- Vincerx Pharma, Inc. earnings per share, diluted for the quarter ending 2024-09-30 was -$15.85.
- Vincerx Pharma, Inc. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.05.
- Vincerx Pharma, Inc. earnings per share, diluted for fiscal 2024 was -$15.85.
- Vincerx Pharma, Inc. earnings per share, diluted for fiscal 2023 was -$37.72.
- Vincerx Pharma, Inc. earnings per share, diluted for fiscal 2022 was -$3.00.
- Vincerx Pharma, Inc. earnings per share, diluted for fiscal 2021 was -$2.29.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$1.40 10-Q · filed 2025-05-15 | $275.43 derived: net income ÷ weighted average shares · filed 2025-05-15 | $1284.09 derived: net income ÷ weighted average shares · filed 2025-05-15 | $8758.46 derived: net income ÷ weighted average shares · filed 2025-05-15 | |||
| 2024-12-31 | $81.63 derived: net income ÷ weighted average shares · filed 2025-03-27 | $606.07 derived: net income ÷ weighted average shares · filed 2025-03-27 | $3802.26 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$15.85 10-K · filed 2025-03-27 | |||
| 2024-09-30 | -$15.85 10-K · filed 2025-03-27 | -$0.17 10-Q · filed 2024-11-12 | -$229.76 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.63 10-Q · filed 2024-11-12 | -$4231.87 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||
| 2024-06-30 | -$0.05 10-Q · filed 2024-08-08 | -$0.48 10-Q · filed 2024-08-08 | $2860.46 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$92288.05 derived: net income ÷ weighted average shares · filed 2025-05-15 | |||
| 2024-03-31 | -$11.46 10-Q · filed 2025-05-15 | -$0.58 10-Q · filed 2024-05-14 | $594.54 derived: net income ÷ weighted average shares · filed 2025-05-15 | $2132.66 derived: net income ÷ weighted average shares · filed 2025-05-15 | $9577.98 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||
| 2023-12-31 | $83.13 derived: net income ÷ weighted average shares · filed 2025-03-27 | $730.69 derived: net income ÷ weighted average shares · filed 2025-03-27 | $4520.38 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$37.72 10-K · filed 2025-03-27 | -$1.89 10-K · filed 2024-03-29 | ||
| 2023-09-30 | -$37.72 10-K · filed 2025-03-27 | -$0.46 10-Q · filed 2023-11-14 | -$964.69 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.66 10-Q · filed 2024-11-12 | -$2188.05 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$0.54 10-Q · filed 2024-08-08 | -$0.52 10-Q · filed 2023-08-07 | -$1.23 10-Q · filed 2024-08-08 | -$1.20 10-Q · filed 2023-08-07 | -$1766.93 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2566.64 derived: net income ÷ weighted average shares · filed 2024-08-08 | |
| 2023-03-31 | -$0.69 10-Q · filed 2024-05-14 | -$0.68 10-Q · filed 2023-05-11 | -$1224.25 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2024.36 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2900.74 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||
| 2022-12-31 | -$532.64 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$1332.88 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$2209.50 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$3.00 10-K · filed 2024-03-29 | -$3.11 10-K · filed 2023-03-28 | ||
| 2022-09-30 | -$0.80 10-Q · filed 2023-11-14 | -$1677.84 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$2.46 10-Q · filed 2023-11-14 | -$2776.03 derived: net income ÷ weighted average shares · filed 2023-11-14 | |||
| 2022-06-30 | -$0.88 10-Q · filed 2023-08-07 | -$1.66 10-Q · filed 2023-08-07 | -$1974.62 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$3272.98 derived: net income ÷ weighted average shares · filed 2023-08-07 | |||
| 2022-03-31 | -$0.79 10-Q · filed 2023-05-11 | -$1096.11 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2392.09 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2608.99 derived: net income ÷ weighted average shares · filed 2023-05-11 | |||
| 2021-12-31 | -$309.95 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1607.05 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1804.10 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$2.29 10-K · filed 2023-03-28 | |||
| 2021-09-30 | -$1.39 10-Q · filed 2022-11-10 | -$1560.22 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.06 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$0.12 10-Q · filed 2022-08-11 | -$0.55 10-Q · filed 2022-08-11 |